Author: Erin Briesath

Assistant Professor; Co-Director, Clerkship ProgramSpecialty: Maternal-Fetal Medicine...

In the 5-year follow-up of the pivotal SOLO-1 trial in women with advanced ovarian cancer and a BRCA1/2 mutation, maintenance treatment with olaparib led to a doubling in progression-free survival. William H. Bradley, MD, presented these findings at the Society of Gynecologic Oncology (SGO) 2021...